These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1413068

  • 21. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract] [Full Text] [Related]

  • 22. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H, Miyano T, Yamataka A, Yamataka T, Yagita H, Eto H, Ligo Y, Tansyo S, Kojima Y, Tamatani T.
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [Abstract] [Full Text] [Related]

  • 23. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M, Suzuki J, Yamazaki S, Sekiguchi M.
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract] [Full Text] [Related]

  • 24. Dose-dependent effect of intrathymically injected 3-mol/L KCl-extracted histocompatibility antigens to prolong heart allograft survival in rats.
    Hamashima T, Stepkowski SM, Kahan BD.
    Transplant Proc; 1995 Feb; 27(1):134-5. PubMed ID: 7878904
    [No Abstract] [Full Text] [Related]

  • 25. FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies.
    Moffatt SD, Metcalfe SM.
    Transplant Proc; 1999 Nov; 31(7):2740. PubMed ID: 10578271
    [No Abstract] [Full Text] [Related]

  • 26. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M, Ihara A.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract] [Full Text] [Related]

  • 27. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
    Stepkowski SM, Tu Y, Condon TP, Bennett CF.
    Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
    [No Abstract] [Full Text] [Related]

  • 28. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ, Gill RG, Gelhaus HC, Doan AN, Sleater ML, Pietra BA.
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [Abstract] [Full Text] [Related]

  • 29. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L, Woo J, Buelow R.
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H, Seino K, Kano M, Sato K, Azuma M, Yagita H, Okumura K.
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract] [Full Text] [Related]

  • 34. Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival.
    Lussow AR, Fanget L, Gao L, Buelow R, Pouletty P.
    Transplant Proc; 1996 Apr; 28(2):571-2. PubMed ID: 8623277
    [No Abstract] [Full Text] [Related]

  • 35. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

  • 36. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness.
    Saitovitch D, Bushell AR, Morris PJ, Wood KJ.
    Transplant Proc; 1995 Feb; 27(1):117-8. PubMed ID: 7878834
    [No Abstract] [Full Text] [Related]

  • 37. The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse.
    Bueno V, Binet I, Steger U, Bundick R, Ferguson D, Murray C, Donald D, Wood K.
    Transplantation; 2007 Nov 15; 84(9):1204-7. PubMed ID: 17998878
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS.
    J Immunol; 1993 Dec 15; 151(12):7249-59. PubMed ID: 7903105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.